{"nctId":"NCT01048242","briefTitle":"Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)","startDateStruct":{"date":"2006-07"},"conditions":["Insomnia","Obstructive Sleep Apnea"],"count":27,"armGroups":[{"label":"Ramelteon","type":"EXPERIMENTAL","interventionNames":["Drug: rozerem"]},{"label":"sugar pill","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"rozerem","otherNames":["Ramelteon"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Obstructive sleep apnea\n* Insomnia\n* Age\\>60\n\nExclusion Criteria:\n\n* Cognitive impairment\n* Active alcohol or substance abuse\n* Active use of other sedative-hypnotic agents\n* Active use of fluvoxamine (drug interaction with Ramelteon\n* Evidence of hepatic dysfunction (Ramelteon contraindicated) on liver function panel\n* Presence of Periodic Limb Movement Disorder or Restless Legs Syndrome\n* Severe Chronic Obstructive Pulmonary Disease","healthyVolunteers":false,"sex":"ALL","minimumAge":"60 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Sleep Onset Latency","description":"Time to sleep onset as determined by polysomnography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.7","spread":"10.3"},{"groupId":"OG001","value":"34.4","spread":"30.7"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":8},"commonTop":["Skin ulcer","Paranasal sinusitis","Diarrhea","Fracture","Abdominal pain"]}}}